You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
Dow
Colorcon

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Cypress Pharm Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CYPRESS PHARM, and what generic and branded alternatives to CYPRESS PHARM drugs are available?

CYPRESS PHARM has five approved drugs.



Summary for Cypress Pharm
US Patents:0
Tradenames:5
Ingredients:4
NDAs:5

Drugs and US Patents for Cypress Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cypress Pharm Inc ZYFREL acetaminophen; hydrocodone bitartrate SOLUTION;ORAL 090468-001 Apr 14, 2016 DISCN No No   Start Trial   Start Trial
Cypress Pharm ELIPHOS calcium acetate TABLET;ORAL 078502-001 Nov 25, 2008 DISCN No No   Start Trial   Start Trial
Cypress Pharm CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 090418-001 May 4, 2010 DISCN No No   Start Trial   Start Trial
Cypress Pharm CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090417-001 Aug 23, 2010 DISCN No No   Start Trial   Start Trial
Cypress Pharm CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090300-002 Oct 10, 2008 DISCN No No   Start Trial   Start Trial
Cypress Pharm CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride SYRUP;ORAL 090300-001 Oct 10, 2008 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Express Scripts
AstraZeneca
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.